Investment
Features
FeesSafety
Academy
More
Pluang+

Cognex launches In-Sight 1750 to boost semiconductor wafer tracking and production efficiency.

Others
23 Sep 2026
PRNewsWire
View Source
Bullish
Cognex launches In-Sight 1750 to boost semiconductor wafer tracking and production efficiency.

Cognex Corporation introduced the In-Sight 1750 Series, an advanced wafer and panel identification system designed to help semiconductor manufacturers improve traceability, reduce production disruptions, and maintain throughput. This system uses AI and advanced imaging to reliably read difficult wafer markings, supporting the growing demand for semiconductors in AI and advanced electronics. It enables faster upgrades and higher equipment utilization without major process changes, helping chipmakers scale production while maintaining quality. The In-Sight 1750 also offers a user-friendly setup and supports seamless transition from previous models.

Cognex's new wafer reader is the subject, with Pluang's Technology sector market data providing context. As of Sep 23, 2026 19:52 WIB, out of 150 priced Technology-sector US stocks tradable on Pluang, 71 rose and 72 fell. Among notable movers, Rigetti Computing Inc (RGTI) rose 5.27% to USD 17.39 with a typical hold time of 32 days and predominantly sell orders at 91%, while Applovin Corporation (APP) dropped 3.26% to USD 318.00 with a shorter hold time of 19 days and 80% buy orders, contrasting with Expensify Inc (EXFY) which gained 2.98% to USD 2.42 and had 96% sell orders over a 40-day hold period.

More News

General Mills beats Q1 revenue and EPS estimates but reports a sharp profit decline.

General Mills beats Q1 revenue and EPS estimates but reports a sharp profit decline.

General Mills reported fiscal Q1 earnings with an EPS of $0.75, beating analyst expectations of $0.72, and revenue of $4.39 billion, surpassing the $4.35 billion estimate. The strong revenue was driven by increased demand for pantry staples and break...

Company Fundamentals
Neutral
2 hours ago
Amgen's price target raised after successful Sjögren's disease drug trial.

Amgen's price target raised after successful Sjögren's disease drug trial.

Amgen's stock price target was raised to $410 following positive results from its experimental drug dazodalibep in a late-stage trial for Sjögren's disease. The drug showed significant improvement in patients' symptoms, with effects seen as early as ...

Analyst Insights
Bullish
2 hours ago
Worthington Enterprises beats Q1 earnings estimates with 13% revenue growth and raises dividends.

Worthington Enterprises beats Q1 earnings estimates with 13% revenue growth and raises dividends.

Worthington Enterprises reported strong Q1 fiscal 2027 results, beating analyst earnings estimates with $0.82 per share versus $0.75 expected. The company posted $343.90 million in revenue, a 13% increase year-over-year, driven by acquisitions and or...

Company Fundamentals
Bullish
4 hours ago
Ethereum nears $2,750 after breaking resistance, eyeing $3,000 next amid strong demand and low supply.

Ethereum nears $2,750 after breaking resistance, eyeing $3,000 next amid strong demand and low supply.

Ethereum recently broke above a key resistance level around $2,661, holding near $2,750 and setting sights on the $3,000 mark. The move follows a bullish pattern and is supported by a tightening supply, with exchange reserves at a multi-year low and ...

Technical Signals
Bullish
4 hours ago
Bitcoin nears $90K as ETFs draw nearly $1B in one day, signaling strong institutional demand.

Bitcoin nears $90K as ETFs draw nearly $1B in one day, signaling strong institutional demand.

Bitcoin recently surged to about $87,300, approaching the key $90,000 resistance level. This rally is backed by nearly $1 billion in inflows into U.S. spot Bitcoin ETFs in a single day, indicating strong institutional interest. A sustained break abov...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App